However, what triggers increased trafficking of effectors of Hippo pathway to the nucleus of SSc SFRP2+ FB and activates the fibroblast to myofibroblast differentiation remains unclear and will be the focus of future studies. The gene discussed is SFRP2; the disease is systemic sclerosis.